Leading medical technology company, Smith & Nephew, has announced the launch of its new generation handheld robotics platform – the CORI Surgical System, and its Real Intelligence brand of enabling technology solutions.
Real Intelligence targets a range of clinical challenges including patient engagement, pre and post-operative planning, surgery (digital and robotic) and outcome measurement. Each element in the Real Intelligence digital ecosystem informs the next phase of treatment, which over time will enable healthcare providers to use outcomes data to better inform patient specific treatments.
The new CORI surgical platform – now available for both unicompartmental knee arthroplasty and total knee arthroplasty – is small and portable, making it ideal for ambulatory surgery centers (ASCs) and outpatient surgery. CORI includes new camera technology which is over four times faster, offers more efficient cutting technology with twice the cutting volume, and aims to result in a faster robotic surgical procedure compared to the NAVIO™ Surgical System.1 CORI is surgeon-controlled handheld robotics, and its modular design will enable it to be scaled across the orthopaedic service line. Smith+Nephew will continue to introduce new applications for this robotics platform.
“The CORI Surgical System is truly next generation robotics. Its efficient handheld form factor is ideal for surgery centers, which is where the market is moving, and it just erases away bone with the new bone milling technique,” said Dr. Jimmy Chow, Orthopaedic Surgeon for Hip and Knee, Orthopedic Institute of the West. “The smart, intuitive software helps place and size the implant as well as balance gaps based on patient specific anatomy and disease state.”
“The Real Intelligence brand is a statement of how Smith+Nephew thinks, innovates, and reimagines surgery,” said Skip Kiil, President of Orthopaedics for Smith+Nephew. “The introduction of the CORI Surgical System’s handheld robotics, patient engagement tools, and outcomes measurement are the very first steps in a long-term strategy to advance orthopaedics using technology.”
The CORI Surgical System has received 510K clearance from the United States Food and Drug Administration (FDA) and is available for sale in the US for both total and unicompartmental knee arthroplasty applications. For more information, please visit www.real-intelligence.com.
Reference: 1. Data on file with Smith+Nephew. CORI and NAVIO Technical Specification Comparison, March 2020. Internal Report ER0488 REVA.